SciSparc (SPRC) Free Cash Flow (2016 - 2020)
SciSparc (SPRC) posted Free Cash Flow of -$2.8 million for Q4 2018, down 210.67% sequentially from -$900000.0 in Q3 2018, and down 81.44% YoY from -$15.1 million in Q4 2017.
SciSparc (SPRC) Free Cash Flow (2016 - 2020) Analysis & Trends
SciSparc has reported Free Cash Flow for 3 years, with the latest figure at -$2.8 million in Q4 2018.
- Quarterly Free Cash Flow fell 81.44% year-over-year to -$2.8 million in Q4 2018, while the trailing twelve-month figure through Dec 2019 was -$2.8 million (up 60.89% YoY) and the FY2025 annual result came in at -$4.1 million, up 19.07% from the prior year.
- Free Cash Flow declined to -$2.8 million in Q4 2018 per SPRC's latest filing, from -$900000.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at -$27000.0 in Q4 2016 and troughed at -$2.8 million in Q4 2018.
- A 3-year average of -$1.2 million and a median of -$995000.0 in 2017 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2017 and 2018: Free Cash Flow sank 5607.41% in 2017, then increased 9.55% in 2018.
- Over 3 years, Free Cash Flow stood at -$27000.0 in 2016, then tumbled by 5607.41% to -$1.5 million in 2017, then tumbled by 81.44% to -$2.8 million in 2018.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$2.8 million, -$900000.0, and -$1.8 million for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -427,000.00 |
| Jun 30, 2020 | -427,000.00 |
| Dec 31, 2018 | -2.80 Mn |
| Dec 31, 2018 | -2.80 Mn |
| Sep 30, 2018 | -900,000.00 |
| Sep 30, 2018 | -900,000.00 |
| Jun 30, 2018 | -1.83 Mn |
| Jun 30, 2018 | -1.83 Mn |
| Mar 31, 2018 | -1.62 Mn |
| Mar 31, 2018 | -1.62 Mn |
| Dec 31, 2017 | -1.54 Mn |
| Dec 31, 2017 | -1.54 Mn |
| Sep 30, 2017 | -995,000.00 |
| Sep 30, 2017 | -995,000.00 |
| Jun 30, 2017 | -1.89 Mn |
| Jun 30, 2017 | -1.89 Mn |
| Mar 31, 2017 | -194,000.00 |
| Mar 31, 2017 | -194,000.00 |
| Dec 31, 2016 | -27,000.00 |
| Dec 31, 2016 | -27,000.00 |